Gastrofarm tablets, no. 6

• acute and chronic gastritis, accompanied by increased acidity of gastric juice;

• peptic ulcer of the stomach and duodenum;

• as a prophylactic agent during and after treatment with drugs that have an irritating effect on the gastrointestinal tract;

• as a prophylactic agent after errors in the diet (food intake that causes an increase in gastric acidity) and excessive consumption of alcohol and smoking.

The tablets are taken orally 30 minutes before meals, chewed with a small amount of water or pre-crushed and mixed with a small amount of boiled water at room temperature.

For acute and chronic gastritis and with increased acidity of gastric juice, the drug is prescribed for adults in 1-2 tabs. 3 times / day; children aged 3 to 12 years - 1/2 tab., aged 12 to 18 years - 1 tab. 3 times / day The course of treatment is 30 days.

With acute gastritis and insufficient effectiveness of therapy, the daily dose can be doubled.

The effect is usually observed by the end of the first week of treatment.

In case of gastric ulcer and duodenal ulcer, adults are prescribed 3-4 tab. 3 times / day for 30 days.

For prophylaxis, the drug is used in a dose of 1-2 tab. 3 times / day for 15 days, with alcohol or smoking abuse - 1-2 tab. 2-3 times / day

substance - 1.575 g,

containing dried viable cells of Lactobacillus delbrueckii spp. bulgaricus strain 51 (LB-51) at least 1 ? 102 cells,

and:

protein from 25 to 35%, which in terms of total nitrogen is from 4 to 5.6%

lactic acid from 6.3 to 12.6%

Excipients: sucrose - no more than 0.9 g, magnesium stearate - 0.025 g.

• Individual intolerance to the components.

• Children under 3 years old.

Clinical and pharmacological group: A drug that has a protective effect on the mucous membrane of the stomach and duodenum

Pharmaco-therapeutic group: MIBP-eubiotic

pharmachologic effect

A drug that has a protective effect on the mucous membrane of the stomach and intestines.

The action of the drug is ensured by the presence of Lactobacillus bulgaris and biologically active products of their vital activity (lactic and malic acid, nucleic acids, a number of alpha-amino acids, polypeptides and polysaccharides), as well as a high content of proteins (25-30%), which have a protective effect on the mucous membrane Gastrointestinal tract, stimulating regeneration processes in the mucous membrane of the stomach and duodenum. The drug also has an analgesic and antacid effect due to the buffering properties of the protein that is part of the drug.

Pharmacokinetics

Data on the pharmacokinetics of Gastrofarm are not provided.

Indications

• acute and chronic gastritis, accompanied by increased acidity of gastric juice;

• peptic ulcer of the stomach and duodenum;

• as a prophylactic agent during and after treatment with drugs that have an irritating effect on the gastrointestinal tract;

• as a prophylactic agent after errors in the diet (food intake that causes an increase in gastric acidity) and excessive consumption of alcohol and smoking.

Dosage regimen

The tablets are taken orally 30 minutes before meals, chewed with a small amount of water or pre-crushed and mixed with a small amount of boiled water at room temperature.

For acute and chronic gastritis and with increased acidity of gastric juice, the drug is prescribed for adults in 1-2 tabs. 3 times / day; children aged 3 to 12 years - 1/2 tab., aged 12 to 18 years - 1 tab. 3 times / day The course of treatment is 30 days.

With acute gastritis and insufficient effectiveness of therapy, the daily dose can be doubled.

The effect is usually observed by the end of the first week of treatment.

In case of gastric ulcer and duodenal ulcer, adults are prescribed 3-4 tab. 3 times / day for 30 days.

For prophylaxis, the drug is used in a dose of 1-2 tab. 3 times / day for 15 days, with alcohol or smoking abuse - 1-2 tab. 2-3 times / day

Contraindications:

• Individual intolerance to the components.

• Children under 3 years old.

Side effect

When using the drug according to the indications in the recommended doses, no side effects have been identified.

Application during pregnancy and lactation

Data on the use of the drug during pregnancy and lactation (breastfeeding) are not provided.

Application in children

The drug is prescribed for children over 3 years old (see Dosage regimen).

special instructions

The drug is harmless, non-toxic.

When prescribing the drug to patients with diabetes mellitus, it should be borne in mind that in 1 tab. contains 0.9 g of sucrose.

Influence on the ability to drive vehicles and use mechanisms

The drug does not affect the ability to drive vehicles.

Overdose

Currently, no cases of overdose of Gastrofarm have been described.

Drug interactions

The drug interaction of the Gastrofarm drug has not been established and the drug can be used with other drugs.

Storage conditions

The drug should be stored in a dry, dark place, out of the reach of children, at a temperature not exceeding 25 ? C.

Shelf life

Shelf life is 2 years.

Terms of sale

The drug is approved for use as a means of OTC.